Fibrin Glue Sac Filling for Preventing Type II Endoleak, Short-Term Outcomes of a Prospective Randomized Controlled Trial.
Yonghui ChenLei ZhangZongwei LiuJiaxue BiFang NiuXiaoxing ZhangQing-Sheng LuXiangchen DaiPublished in: Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists (2023)
Standard endovascular aneurysm repair (EVAR) couldn't prevent type II endoleak (T2EL). In this study, we found fibrin glue sac filling (FGSF) could prevent T2EL and promote AAA shrinkage in a short term. And the FGSF procedure is easy, it will be a useful supplement to standard EVAR for clinicians. And FGSF might have potential usefulness on ruptured aneurysms, although without direct evidence.Fibrin glue is often used to hemostasis and tissue adhesion in surgical patients and burn patients, we firstly carry out a randomized controlled study and prove that fibrin glue sac filling could prevent T2EL and promote sac remodeling.
Keyphrases
- randomized controlled trial
- platelet rich plasma
- abdominal aortic aneurysm
- end stage renal disease
- ejection fraction
- newly diagnosed
- study protocol
- peritoneal dialysis
- palliative care
- minimally invasive
- systematic review
- patient reported outcomes
- clinical trial
- risk assessment
- pseudomonas aeruginosa
- patient reported